+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 4Weeks - 17Years
All Genders
ID07791914

Early Oral Antibiotic Switch Compared to Standard Intravenous Therapy in Children and Adolescents with Bloodstream Infections

Led by Ulrikka Nygaard · Updated on 2026-10-19

150

Participants Needed

18

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effectiveness of early oral antibiotic switching compared to standard intravenous IV antibiotic therapy in children and adolescents aged 4 weeks to 17 years with uncomplicated bloodstream infections. This nationwide, multicenter, randomized, open-label trial aims to determine if starting oral antibiotics early is not worse than continuing IV antibiotics regarding treatment failure. The study addresses the need for higher quality evidence in managing bloodstream infections in previously healthy young patients. Participants are randomly assigned to either an early oral switch group or a standard IV therapy group. The early oral switch group changes to oral antibiotics as soon as the child is clinically stable and within 4 days after starting IV antibiotics some children may start on oral antibiotics without prior IV treatment. The standard IV therapy group receives IV antibiotics for at least 5 days, typically 7, before switching to oral therapy if appropriate. Antibiotic choice and total treatment duration depend on the infection and follow local guidelines. Throughout the study, children are monitored for treatment failure within 8 weeks after randomization. Clinical stability, improvement, and tolerance to oral intake are assessed by investigators. The main outcome is the number of participants who experience treatment failure. Secondary outcomes include the duration of IV antibiotic treatment. The trial plans to enroll at least 150 participants over approximately three years, with follow-up and safety monitoring continuing until the end of the study period.

CONDITIONS

Brief Title

Oral Switch in Pediatric Bloodstream Infections

Research Team

U

Ulrikka Nygaard, MD, PhD, DMSc

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here